A

Asian Phytoceuticals PCL
SET:APCO

Watchlist Manager
Asian Phytoceuticals PCL
SET:APCO
Watchlist
Price: 5.25 THB Market Closed
Market Cap: 3.2B THB
Have any thoughts about
Asian Phytoceuticals PCL?
Write Note

Asian Phytoceuticals PCL
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Asian Phytoceuticals PCL
Income from Continuing Operations Peer Comparison

Comparables:
D
DDD
T
TNR
I
IP
K
KAMART
D
DOD

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
A
Asian Phytoceuticals PCL
SET:APCO
Income from Continuing Operations
฿81.6m
CAGR 3-Years
10%
CAGR 5-Years
1%
CAGR 10-Years
-3%
D
Do Day Dream PCL
SET:DDD
Income from Continuing Operations
฿6.3m
CAGR 3-Years
-71%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
T
Thai Nippon Rubber Industry PCL
SET:TNR
Income from Continuing Operations
฿592.7m
CAGR 3-Years
49%
CAGR 5-Years
22%
CAGR 10-Years
N/A
I
Inter Pharma PCL
SET:IP
Income from Continuing Operations
฿58.9m
CAGR 3-Years
0%
CAGR 5-Years
15%
CAGR 10-Years
N/A
K
Karmarts PCL
SET:KAMART
Income from Continuing Operations
฿727m
CAGR 3-Years
74%
CAGR 5-Years
14%
CAGR 10-Years
16%
D
DOD Biotech PCL
SET:DOD
Income from Continuing Operations
-฿163.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Asian Phytoceuticals PCL's Income from Continuing Operations?
Income from Continuing Operations
81.6m THB

Based on the financial report for Jun 30, 2024, Asian Phytoceuticals PCL's Income from Continuing Operations amounts to 81.6m THB.

What is Asian Phytoceuticals PCL's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-3%

Over the last year, the Income from Continuing Operations growth was -24%. The average annual Income from Continuing Operations growth rates for Asian Phytoceuticals PCL have been 10% over the past three years , 1% over the past five years , and -3% over the past ten years .

Back to Top